Details Basic Details Status Ongoing Last Updated Friday, July 10, 2020 Health Outcome(s) adverse central nervous system reactions, tardive dyskinesia Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR Yes Regulatory Link(s) (1) FDA Approval Package Materials